Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

A tétel rövid nézete
dc.contributor.authorSpelman, Tim
dc.contributor.authorHerring, W. L.
dc.contributor.authorAcosta, C.
dc.contributor.authorHyde, R.
dc.contributor.authorJokubaitis, Vilija
dc.contributor.authorPucci, Eugenio
dc.contributor.authorLugaresi, Alessandra
dc.contributor.authorLaureys, Guy
dc.contributor.authorHavrdova, Eva
dc.contributor.authorHorakova, Dana
dc.contributor.authorIzquierdo, Guillermo
dc.contributor.authorEichau, Sara
dc.contributor.authorOzakbas, Serkan
dc.contributor.authorAlroughani, Raed
dc.contributor.authorKalincik, Tomas
dc.contributor.authorDuquette, Pierre
dc.contributor.authorGirard, Marc
dc.contributor.authorPetersen, Thor
dc.contributor.authorPatti, Francesco
dc.contributor.authorCsépány, Tünde
dc.contributor.authorGranella, Franco
dc.contributor.authorGrand'Maison,, Francois
dc.contributor.authorFerraro, D.
dc.contributor.authorKarabudak, Rana
dc.contributor.authorJosé Sá, Maria
dc.contributor.authorTrojano, Maria
dc.contributor.authorPesch, Vincent van
dc.contributor.authorWijmeersch, Bart Van
dc.contributor.authorCartechini, Elisabetta
dc.contributor.authorMcCombe, Pamela
dc.contributor.authorGerlach, Oliver
dc.contributor.authorSpitaleri, Daniele
dc.contributor.authorRózsa, Csilla
dc.contributor.authorHodgkinson, Suzanne
dc.contributor.authorBergamaschi, Roberto
dc.contributor.authorGouider, Riadh
dc.contributor.authorSoysal, Aysun
dc.contributor.authorPrevost, Julie
dc.contributor.authorGarber, Justin
dc.contributor.authorde Gans, Koen
dc.contributor.authorAmpapa, Radek
dc.contributor.authorSimó, Magdolna
dc.contributor.authorSanchez-Menoyo, Jose
dc.contributor.authorIuliano, Gerardo
dc.contributor.authorSas, Attila
dc.contributor.authorWalt, Anneke van der
dc.contributor.authorJohn, Nevin
dc.contributor.authorGray, Orla
dc.contributor.authorHughes, Stella
dc.contributor.authorDe Luca, Giacomo
dc.contributor.authorOnofrj, Marco
dc.contributor.authorBuzzard, Katherine
dc.contributor.authorSkibina, Olga
dc.contributor.authorTerzi, Murat
dc.contributor.authorSlee, Mark
dc.contributor.authorSolaro, Claudio
dc.contributor.authorRamo-Tello, Cristina
dc.contributor.authorFragoso, Yara
dc.contributor.authorShaygannejad, Vahid
dc.contributor.authorMoore, Fraser
dc.contributor.authorRajda, Cecília
dc.contributor.authorAguera-Morales, Eduardo
dc.contributor.authorButzkueven, Helmut
dc.date.accessioned2024-03-06T13:15:40Z
dc.date.available2024-03-06T13:15:40Z
dc.date.issued2024
dc.date.oa2024-04-11
dc.date.pasync2024-12-21T00:06:43Z
dc.date.updated2024-03-06T13:15:40Z
dc.description.correctorkzs
dc.identifier.citationJournal of Medical Economics. -27 : 1 (2024), p. 109-125. -J Med Econ. - 1369-6998. - 1941-837X
dc.identifier.doihttp://dx.doi.org/10.1080/13696998.2023.2293379
dc.identifier.issn1941-837X
dc.identifier.issn1369-6998
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM119143
dc.identifier.scopus85181176590
dc.identifier.urihttps://hdl.handle.net/2437/367198
dc.identifier.urlhttps://www.tandfonline.com/doi/full/10.1080/13696998.2023.2293379
dc.identifier.wos001130397900001
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabElméleti orvostudományok
dc.titleComparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in th.pdf
Méret:
2.61 MB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis